Older men whose testosterone levels drop or are medically suppressed face a measurably higher risk of age-related macular ...

School-based programmes may prevent adolescents from starting to use electronic cigarettes (e-cigarettes) and a community-based programme delivered by text message probably helps adolescents quit ...

Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...

A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded ...

Both a DEA lawyer and an FDA official spoke to justify rescheduling—arguments that were condemned by a prominent ...

Deramiocel demonstrates durable skeletal and cardiac muscle benefit over five years in the HOPE-2 OLE studyPUL 2.0 year-over-year decline ...

Following semaglutide's approval, poison center reports of GLP-1 RA exposures doubled, revealing critical trends in patient ...

Background Improvement science has supported the methodological foundations for the application of quality improvement (QI) ...

Adults with type 2 diabetes may have lower risk for fractures if they use semaglutide compared with other medications, according to data presented at ENDO 2026. As Healio previously reported, a ...

This joint-specific response pattern was consistent across all advanced treatment modalities, including abatacept, interleukin-6 receptor inhibitors, Janus kinase inhibitors, rituximab and TNFi.

The agency took another step toward clearing a backlog of Makary-era rejections that appeared to contradict earlier ...

GLP-1 receptor agonists may lower the likelihood of psychiatric treatment intensification in patients with type 2 diabetes and depression.